Search Results

As the price of new cancer treatments continues to rise, physicians in both the inpatient and outpatient settings need to factor cost as well as efficacy into treatment plans. Julie Kennerly-Shah, PharmD, MS, MHA, facilitates the Hematology Oncology Pharmacy and Therapeutics (P&T) Committee at The Ohio State University Comprehensive Cancer Center, determining which agents will be available to providers …

A multidisciplinary approach allows the formation of partnerships between expert professionals that extends beyond the boundaries of their individual specialties, reduces the potential for miscommunication, and eliminates the fragmentation of services that was once common in cancer care.